Contact us Demo our platform

METABOLON @

AACR Annual Meeting 2024
(American Association for Cancer Research)

  • San Diego Conference Center, California, USA
  • April 5 - April 10 2024
  • Booth #3458

Metabolon is thrilled to return as an exhibitor at the AACR Annual Meeting 2024.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Metabolomics can offer insights into the dynamic metabolic alterations underlying cancer development and progression. It enables the comprehensive profiling of small molecules within cells, tissues, and biofluids, unveiling metabolic signatures specific to different cancer types and stages. These signatures serve as potential biomarkers for early detection, prognosis, and treatment response assessment, facilitating personalized cancer care. Moreover, metabolomics integration with other omics can enhance our understanding of cancer biology and facilitate the discovery of innovative diagnostic and therapeutic strategies.

For more event information, you can read visit the official event website or read the official program.

Join us at Booth #3458

Join us at booth #3458 to discover how Metabolon’s metabolomics services can advance your cancer research. Schedule a meeting here to guarantee 1:1 time with a metabolomics expert. 

Event Location

San Diego Convention Center
111 Harbor Dr, San Diego, CA 92101, United States
Google Maps

Why Metabolomics: Your Guide to Metabolomics

In this guide, we explore the ins and outs of one of the most powerful omics tools in any scientist’s toolbox, one that can complement any existing workflow and help realize the full potential of other omics methods: metabolomics.

Read now

Schedule a Meeting

Meet the Reps Attending AACR 2024

Joey Qiu

Joey Qiu

Biotech Specialist

Joey Qiu is a dedicated and enthusiastic professional with a passion for driving innovation in the field of metabolomics. With a background in molecular biology and a keen interest in understanding complex biological systems, Joey has worked in the biotech industry in Los Angeles for over 12 years. As a representative of Metabolon, Inc., Joey is committed to fostering collaborations and leveraging cutting-edge technologies to advance scientific research.

Mia Chagoya

Mia Chagoya

Microbiology Specialist

Mia has been assisting clients in the healthcare, biotech, and pharma industries on the West Coast for over nine years. With a background in Microbiology and Mass Spectrometry, she has experience in a variety of application areas including human health research, microbiome, and diagnostics. Joining Metabolon in 2022, Mia takes pride in understanding our clients research and personal goals to identify the best path to success in generating and applying metabolomics data.

Sinem Taylor

Sinem Taylor

Sinem Taylor is an enthusiastic sales professional with a strong background in life sciences and genomics. With over 10 years of industry experience, she is passionate about helping researchers and organizations harness the power of metabolomics to advance scientific discoveries.

Katie Steward, Ph.D.

Katie Steward, Ph.D.

Mass Spectrometry Expert

Katie Steward has been working in analytical chemistry for over fifteen years. A mass spectrometry expert, Katie has worked across a variety of application areas, including agriculture, academia, and human health research. Katie’s academic career focused on metabolomics and proteomics to interrogate systemic variability in a myriad of different biological systems. She joined Metabolon in 2022 as a Field Metabolomics Scientist to help bring high-fidelity data to researchers spanning disciplines from drug discovery to crop yield optimization. Marrying the small molecule profile with other omics and analyzing data from a new perspective are what excite Katie the most about metabolomics.

✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.